Resources

This is the first study ever to evaluate WelChol in combination with insulin, and it demonstrated A1C reductions of 0.5%.

A U.S. decision on approving Novartis AG’s key diabetes drug Galvus has been delayed by three months after the firm asked the Food and Drug Administration to consider new clinical trials data.

Fasting glucose (FG) levels increase in older adults with hypertension regardless of whether they are treated with chlorthalidone, amlodipine, or lisinopril.

With one in two having diabetes, it could wipe out Maori and Polynesian Islanders by the end of the century, according to an international expert in the disease.

Accomplia is now approved in Europe and Mexico, US next?

Weight loss from exercise or calorie restriction improved glucose tolerance in nonobese, healthy men and women, according to the results of a randomized controlled trial.

The effects of lifestyle intervention on diabetes risk do not disappear after active counseling has stopped, even after three plus years.

If your patients are overweight, they may have special concerns about doing structured exercise routines. They often become so self-conscious about their bodies during such activities that it prevents them from wanting to participate at all. Sheri Colberg, Ph.D., FACSM helps your patients overcome these fears by discussing Other Unstructured …

A team of scientists in Britain are in the process starting the first study of a closed loop system with 12 children with Type 1 diabetes. The device if successful promises to transform the lives of scores of youngsters.

Acomplia™ (rimonabant) approved in Mexico to treat obese/overweight patients with associated type 2 diabetes or dyslipidemia or to help them improve glycemic control on background of conventional antidiabetic treatment.